Clinical trial
The Utility of Nexium in Chronic Cough and Reflux Disease
NCT00287339 · University of North Carolina, Chapel Hill, Other · Completed
Key facts
| NCT number | NCT00287339 |
|---|---|
| Title | The Utility of Nexium in Chronic Cough and Reflux Disease |
| Official title | Chronic Cough and Reflux Disease: A Randomized, Double-Blinded, Placebo Controlled Trial of High Dose Proton Pump Inhibition |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cough, GERD |
| Intervention type | Drug |
| Interventions | Esomeprazole, Placebo |
| Enrollment | 40 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Feb 6, 2006 |
| Last update posted | Jan 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: